Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.